Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) hired Eli Kalif as EVP and CFO, effective Dec. 22. He succeeds Michael McClellan, who stepped down Friday for personal reasons. Kalif was SVP, finance at Flex Ltd. (NASDAQ:FLEX).

Ipsen Group (Euronext:IPN; Pink:IPSEY) hired Howard Mayer as EVP and head of R&D, effective Dec. 1, to succeed EVP, R&D and CSO Alexandre Lebeaut, who is retiring at year end. Mayer was SVP, CMO and head of R&D, neuroscience division at Shire plc...